grant

Benefits of Intravenous L-Carnitine Supplementation in Long-Term Haemodialysis Patients [ 2008 - 2011 ]

Also known as: Can L-carnitine be used to improve the health of patients receving long-term haemodialysis?

Funded by National Health and Medical Research Council
Managed by University of South Australia
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/511335]

Researchers: Prof Allan Evans (Principal investigator) ,  Prof Randall Faull

Brief description Carnitine allows the body to utilise fats in our diet, permitting normal functioning of the body. The applicants have shown that patients who receive long-term haemodialysis treatment have abnormal levels of carnitine and have demonstrated a link between these abnormal levels and some dialysis-related conditions. This study will determine whether supplementation with L-carnitine is beneficial in the treatment of some clinical disorders experienced by haemodialysis patients.

Funding Amount $AUD 406,648.75

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Anaemia | Biomedical and Clinical Sciences | Dyslipidaemia | Haemodialysis | L-Carnitine | Medical Biochemistry - Inorganic Elements and Compounds | Medical Biochemistry and Metabolomics | Muscle Fatigue | Renal | Renal Diseases | Therapeutics |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA